Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.

Maraolo, Alberto Enrico; Moriello, Nicola Schiano; Gentile, Ivan

doi:10.1016/j.cmi.2024.05.011

Clinical Microbiology and Infection

2024

DOI: 10.1016/j.cmi.2024.05.011

|View full text |Cite

Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.

Alberto Enrico Maraolo,

Nicola Schiano Moriello,

Ivan Gentile

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’: author's response

Meijer,

Paran,

Belkin

et al. 2024

Clinical Microbiology and Infection

View full text Add to dashboard Cite

‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’: author's response

Meijer,

Paran,

Belkin

et al. 2024

Clinical Microbiology and Infection

View full text Add to dashboard Cite

Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis

Maria,

Maraolo,

Cozzolino

et al. 2024

Eur J Med Res

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Re: Persistent COVID-19 in immunocompromised patients—Israeli Society of Infectious Diseases consensus statement on diagnosis and management by Meijer et al.

Cited by 2 publications

References 10 publications

‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’: author's response

‘Persistent COVID-19 in immunocompromised patients – Israeli society of infectious diseases consensus statement on diagnosis and management’: author's response

Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis

Contact Info

Product

Resources

About